Europäische Union -
Deutsch -
EMA (European Medicines Agency)
brukinsa
beigene ireland ltd - zanubrutinib - waldenstrom macroglobulinemia - antineoplastische mittel - brukinsa as monotherapy is indicated for the treatment of adult patients with waldenström’s macroglobulinaemia (wm) who have received at least one prior therapy, or in first line treatment for patients unsuitable for chemo-immunotherapy. brukinsa as monotherapy is indicated for the treatment of adult patients with marginal zone lymphoma (mzl) who have received at least one prior anti-cd20-based therapy. brukinsa as monotherapy is indicated for the treatment of adult patients with chronic lymphocytic leukemia (cll).
Österreich -
Deutsch -
AGES (Agentur für Gesundheit und Ernährungssicherheit)
cosopt sine 20 mg/ml + 5 mg/ml augentropfen, lösung im einzeldosisbehältnis
santen oy - dorzolamid hydrochlorid; timololmaleat - timolol, kombinationen
Deutschland -
Deutsch -
BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)
cosopt-s 20 mg/ml + 5mg/ml augentropfen im einzeldosisbehältnis
santen oy (3332582) - dorzolamidhydrochlorid; timololmaleat - augentropfen - teil 1 - augentropfen; dorzolamidhydrochlorid (26539) 22,26 milligramm; timololmaleat (12113) 6,83 milligramm